Claudio Mosse
机构: Professor of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center
每年引用次数
引用次数
引用: 2,124
H-指数: 22
I10-指数 : 33
出版物: 79
The antigen processing pathway of tyrosinase, a membrane-associated melanoma protein
Claudio Alberto Mosse
University of Virginia
2000
Minimal Residual Disease in Myeloma: Are We There Yet?
Andrew J. Hart , Madan H. Jagasia , Annette S. Kim , Claudio A. Mosse
Biology of Blood and Marrow Transplantation 18 ( 12) 1790 -1799
18
2012
The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol
Claudio A. Mosse , Leslie Meadows , Chance J. Luckey , David J. Kittlesen
Journal of Experimental Medicine 187 ( 1) 37 -48
110
1998
In the Era of Bortezomib-Based Chemotherapy the Presence of Minimal Residual Disease Predicts Progression Free Survival after Autologous Hematopoietic Cell Transplant
Robert F Cornell , Jade E Jones , Claudio A. Mosse , Heidi Chen
Blood 126 ( 23) 5493 -5493
2015
Processing of a Class I-Restricted Epitope from Tyrosinase Requires Peptide N-Glycanase and the Cooperative Action of Endoplasmic Reticulum Aminopeptidase 1 and Cytosolic Proteases
Michelle L. Altrich-VanLith , Marina Ostankovitch , Joy M. Polefrone , Claudio A. Mosse
Journal of Immunology 177 ( 8) 5440 -5450
35
2006
Utilization Analysis in Hematopathology
Annette S. Kim , Claudio A. Mosse , Aaron C. Shaver , Adam C. Seegmiller
Utilization Management in the Clinical Laboratory and Other Ancillary Services 189 -202
2017
Quantitative assessment of myeloid nuclear differentiation antigen distinguishes myelodysplastic syndrome from normal bone marrow.
Sara A. McClintock-Treep , Robert C. Briggs , Keith E. Shults , Leanne A. Flye-Blakemore
American Journal of Clinical Pathology 135 ( 3) 380 -385
9
2011
Optimizing Personalized Bone Marrow Testing Using an Evidence-Based, Interdisciplinary Team Approach
Adam C. Seegmiller , Annette S. Kim , Claudio A. Mosse , Mia A. Levy
American Journal of Clinical Pathology 140 ( 5) 643 -650
21
2013
B-ALL minimal residual disease flow cytometry: an application of a novel method for optimization of a single-tube model.
Aaron C. Shaver , Bruce W. Greig , Claudio A. Mosse , Adam C. Seegmiller
American Journal of Clinical Pathology 143 ( 5) 716 -724
14
2015
Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8
Flavia Guimaraes Nunes Rosado , Yi-Wei Tang , Robert Paul Hasserjian , Colt M. McClain
Human Pathology 44 ( 2) 255 -259
30
2013
A B-cell lymphoma diagnosed in "floater" tissue: implications of the diagnosis and resolution of a laboratory error.
Claudio A. Mosse , Jennifer R. Stumph , D. Hunter Best , Cindy L. Vnencak-Jones
The American Journal of the Medical Sciences 338 ( 3) 248 -251
5
2009
Clinicopathologic correlation of epidemiologic and histopathologic features of pediatric bacterial lymphadenitis.
Flavia G. Nunes Rosado , Charles W. Stratton , Claudio A. Mosse
Archives of Pathology & Laboratory Medicine 135 ( 11) 1490 -1493
14
2011
Evidence-Based, Patient-Specific Guidelines Provide Efficient and Cost-Effective Molecular and Cytogenetic Testing in Hematologic Malignancy
Adam C. Seegmiller , Annette S. Kim , Claudio A. Mosse , Mia A. Levy
Blood 118 ( 21) 2073 -2073
2011
Perineal lymphoma: a diagnostic dilemma.
Rondi M. Kauffmann , Britney L. Grayson , Claudio A. Mosse , Timothy M. Geiger
American Surgeon 80 ( 11) 302 -303
2014
The MD/PhD pathway to a career in laboratory medicine.
Samuel A. Santoro , Claudio A. Mosse , Pampee P. Young
Clinics in Laboratory Medicine 27 ( 2) 425 -434
11
2007
Tyrosinase degradation via two pathways during reverse translocation to the cytosol.
Claudio A. Mosse , Weiting Hsu , Victor H. Engelhard
Biochemical and Biophysical Research Communications 285 ( 2) 313 -319
23
2001
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemia.
Stephen A. Strickland , Aaron C. Shaver , Michael Byrne , Robert D. Daber
Leukemia Research 65 67 -73
6
2018
Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms.
Adam C. Seegmiller , Allison Wasserman , Annette S. Kim , Megan K. Kressin
Leukemia & Lymphoma 55 ( 3) 601 -605
17
2014
Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes
Begum Erdogan , Amma Bosompem , Dunfa Peng , Leng Han
Leukemia & Lymphoma 54 ( 12) 2720 -2727
10
2013
Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma.
Dilan A. Patel , Ragisha Gopalakrishnan , Brian G. Engelhardt , Evonne McArthur
Bone Marrow Transplantation 55 ( 6) 1137 -1146
3
2020